November 30, 1999Roche Laboratories Klonopin
Nutley, NJ (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that Roche Laboratories is recalling Klonopin Tablets
because impurity level exceeds specification.
This ongoing Class III recall was initiated
by the company, August 3, 1999 by letter. This is the first notice the FDA has
issued to the general public of the recall.
This recall affects all lots of:
a) Klonopin (Clonazepam) tablets, 0.5 mg, 25 and 100 tablet units:
b) Klonopin (Clonazepam) tablets, 1 mg, 25 and 100 tablet units;
c) Klonopin (Clonazepam) Tablets, 2 mg, 25 and 100 tablet units.
that have the NDC numbers of 0004-0068-01, 0004-0068-50, 0004-0058-01,
0004-0058-50, 0004-0098-01 and 0004-0098-50.
Over 48,706 pieces were distributed
Questions concerning this recall may
be directed to the FDA at 1-888-INFO-FDA.
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.